Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Curtis who wrote (1662)	4/28/2001 11:11:39 AM
From: Jibacoa	of 2344

John: IMNX: Seems to have good support at 14.75. It still has to deal with yesterday's intra-day double top at the 15.63 level and then with the April 19 H of 16.98. As you may recall the pretty good volume on that day (2,763,700)was mainly on the down-side(the stock closed at 15.75 not far from the intra-day L of 15.30) I still think IMNX has good potential while EMBREL sales keeps booming and the company can't keep up with the demand. I think it has a good chance of getting approved for psoriasis. As far as BIOM is concerned, I think we can expect good news coming at the ASCO meeting in San Francisco in early May. We can also expect an announcement about the "new partner" pretty soon and as the Summer gets closer the possibility of good results on the "Early Look" that may come in late August or September. The stock is maintaining the present up-trend that started at 9.30AM on April 24. The nearest resistance is yesterday's intra-day H of 7.90 which is also close to the Feb8-Feb.9 intra-day double top at 7.87 I am expecting for it, on this run, to test the January 29 intra-day H of 8.91 and may be the January 17 H of 9.25 After that the next hurdle will be the September H at 12.87 RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next